BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 28423035)

  • 1. Genetic profiling of putative breast cancer stem cells from malignant pleural effusions.
    Tiran V; Stanzer S; Heitzer E; Meilinger M; Rossmann C; Lax S; Tsybrovskyy O; Dandachi N; Balic M
    PLoS One; 2017; 12(4):e0175223. PubMed ID: 28423035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of cell arrangement of pleural effusion in survival of patients with breast cancer.
    Camillo ND; Dos Santos GT; Prolla JC; Flôres ER; Introíni GO; Brackmann RL; da Cruz IB; Bica CG
    Acta Cytol; 2014; 58(5):446-52. PubMed ID: 25377597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered expression and activation of the nerve growth factor receptors TrkA and p75 provide the first evidence of tumor progression to effusion in breast carcinoma.
    Davidson B; Reich R; Lazarovici P; Ann Flørenes V; Nielsen S; Nesland JM
    Breast Cancer Res Treat; 2004 Jan; 83(2):119-28. PubMed ID: 14997042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spheres derived from lung adenocarcinoma pleural effusions: molecular characterization and tumor engraftment.
    Mancini R; Giarnieri E; De Vitis C; Malanga D; Roscilli G; Noto A; Marra E; Laudanna C; Zoppoli P; De Luca P; Affuso A; Ruco L; Di Napoli A; Mesiti G; Aurisicchio L; Ricci A; Mariotta S; Pisani L; Andreetti C; Viglietto G; Rendina EA; Giovagnoli MR; Ciliberto G
    PLoS One; 2011; 6(7):e21320. PubMed ID: 21789168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary Adenocarcinoma in Malignant Pleural Effusion Enriches Cancer Stem Cell Properties during Metastatic Cascade.
    Chen SF; Lin YS; Jao SW; Chang YC; Liu CL; Lin YJ; Nieh S
    PLoS One; 2013; 8(5):e54659. PubMed ID: 23658677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast cancer stem cells expressing different stem cell markers exhibit distinct biological characteristics.
    Shao J; Fan W; Ma B; Wu Y
    Mol Med Rep; 2016 Dec; 14(6):4991-4998. PubMed ID: 27840965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression of stem cell protein Piwil2 and piR-932 in breast cancer.
    Zhang H; Ren Y; Xu H; Pang D; Duan C; Liu C
    Surg Oncol; 2013 Dec; 22(4):217-23. PubMed ID: 23992744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome.
    Idowu MO; Kmieciak M; Dumur C; Burton RS; Grimes MM; Powers CN; Manjili MH
    Hum Pathol; 2012 Mar; 43(3):364-73. PubMed ID: 21835433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CytoMatrix for a reliable and simple characterization of lung cancer stem cells from malignant pleural effusions.
    Bruschini S; di Martino S; Pisanu ME; Fattore L; De Vitis C; Laquintana V; Buglioni S; Tabbì E; Cerri A; Visca P; Alessandrini G; Facciolo F; Napoli C; Trombetta M; Santoro A; Crescenzi A; Ciliberto G; Mancini R
    J Cell Physiol; 2020 Mar; 235(3):1877-1887. PubMed ID: 31397494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical detection of breast cancer stem cells in hormone receptor-positive breast cancer and their role in response to endocrine therapy and clinical outcome.
    Hashimoto K; Shimizu C; Tsuda H; Saji S; Osaki A; Shigekawa T; Aogi K
    Oncology; 2012; 82(3):168-74. PubMed ID: 22433454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human lung adenocarcinoma cell cultures derived from malignant pleural effusions as model system to predict patients chemosensitivity.
    Roscilli G; De Vitis C; Ferrara FF; Noto A; Cherubini E; Ricci A; Mariotta S; Giarnieri E; Giovagnoli MR; Torrisi MR; Bergantino F; Costantini S; Fenizia F; Lambiase M; Aurisicchio L; Normanno N; Ciliberto G; Mancini R
    J Transl Med; 2016 Feb; 14():61. PubMed ID: 26928703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Young investigator challenge: The utility of GATA3 immunohistochemistry in the evaluation of metastatic breast carcinomas in malignant effusions.
    Lew M; Pang JC; Jing X; Fields KL; Roh MH
    Cancer Cytopathol; 2015 Oct; 123(10):576-81. PubMed ID: 26465236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microsatellite DNA analysis does not distinguish malignant from benign pleural effusions.
    Economidou F; Tzortzaki EG; Schiza S; Antoniou KM; Neofytou E; Zervou M; Lambiri I; Siafakas NM
    Oncol Rep; 2007 Dec; 18(6):1507-12. PubMed ID: 17982637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential use of loss of heterozygosity in pleural effusions of breast cancer metastases using the microsatellite marker of the 16q22.1 region of the CDH1 gene.
    Granja Nde M; Ricardo SA; Longatto Filho A; Alves VA; Bedrossian CW; Wiley EL; Schmitt FC
    Anal Quant Cytol Histol; 2005 Apr; 27(2):61-6. PubMed ID: 15913197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of EpCAM
    Liu M; Di J; Liu Y; Su Z; Jiang B; Wang Z; Su X
    Cancer Biol Ther; 2018; 19(10):939-947. PubMed ID: 29580161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterizing the HER2/neu status and metastatic potential of breast cancer stem/progenitor cells.
    Pommier SJ; Quan GG; Christante D; Muller P; Newell AE; Olson SB; Diggs B; Muldoon L; Neuwelt E; Pommier RF
    Ann Surg Oncol; 2010 Feb; 17(2):613-23. PubMed ID: 19838757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression, correlation, and prognostic value of TRAF2 and TRAF4 expression in malignant plural effusion cells in human breast cancer.
    Zhao ZJ; Ren HY; Yang F; Wang J; Wu GP; Mi XY
    Diagn Cytopathol; 2015 Nov; 43(11):897-903. PubMed ID: 26331901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The malignant pleural effusion as a model to investigate intratumoral heterogeneity in lung cancer.
    Basak SK; Veena MS; Oh S; Huang G; Srivatsan E; Huang M; Sharma S; Batra RK
    PLoS One; 2009 Jun; 4(6):e5884. PubMed ID: 19536353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of breast cancer metastases in pleural effusions by molecular biology techniques.
    de Matos Granja N; Soares R; Rocha S; Paredes J; Longatto Filho A; Alves VA; Wiley E; Schmitt FC; Bedrossian C
    Diagn Cytopathol; 2002 Oct; 27(4):210-3. PubMed ID: 12357497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of cancer stem cells from different grades of human colorectal cancer.
    Manhas J; Bhattacharya A; Agrawal SK; Gupta B; Das P; Deo SV; Pal S; Sen S
    Tumour Biol; 2016 Oct; 37(10):14069-14081. PubMed ID: 27507615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.